MESULID

This brand name is authorized in Ecuador, Israel

Active ingredients

The drug MESULID contains one active pharmaceutical ingredient (API):

1 Nimesulide
UNII V4TKW1454M - NIMESULIDE

Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation.

Read about Nimesulide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MESULID Tablet MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AX17 Nimesulide M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AX Other antiinflammatory and antirheumatic agents, non-steroids
Discover more medicines within M01AX17
M02AA26 M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 01387-MAC-1-04-11
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3118

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.